NO952825L - Farmasöytisk preparat - Google Patents

Farmasöytisk preparat

Info

Publication number
NO952825L
NO952825L NO952825A NO952825A NO952825L NO 952825 L NO952825 L NO 952825L NO 952825 A NO952825 A NO 952825A NO 952825 A NO952825 A NO 952825A NO 952825 L NO952825 L NO 952825L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
nizatidine
preparation
odorless
disclosed
Prior art date
Application number
NO952825A
Other languages
English (en)
Other versions
NO952825D0 (no
Inventor
Mary Kay Mccauley
Kenneth Philip Moder
Jeffrey Lynn Speakman
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO952825D0 publication Critical patent/NO952825D0/no
Publication of NO952825L publication Critical patent/NO952825L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det er beskrevet et luktløst farmasøytisk preparat av nizatidin. Det er også tilveiebragt en ny form av nizatidin og en fremgangsmåte for fremstilling av denne formen.
NO952825A 1994-08-30 1995-07-17 Farmasöytisk preparat NO952825L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,486 US5470865A (en) 1994-08-30 1994-08-30 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
NO952825D0 NO952825D0 (no) 1995-07-17
NO952825L true NO952825L (no) 1996-03-01

Family

ID=23150736

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952825A NO952825L (no) 1994-08-30 1995-07-17 Farmasöytisk preparat

Country Status (24)

Country Link
US (1) US5470865A (no)
EP (1) EP0704214B1 (no)
JP (1) JPH0892087A (no)
KR (1) KR960006921A (no)
CN (1) CN1127635A (no)
AT (1) ATE192039T1 (no)
AU (1) AU700488B2 (no)
BR (1) BR9503832A (no)
CA (1) CA2157240A1 (no)
CO (1) CO4410183A1 (no)
CZ (1) CZ189395A3 (no)
DE (1) DE69516475T2 (no)
ES (1) ES2145221T3 (no)
FI (1) FI954050A (no)
HU (1) HUT72672A (no)
IL (1) IL115012A0 (no)
NO (1) NO952825L (no)
NZ (1) NZ272833A (no)
PE (1) PE33696A1 (no)
PH (1) PH31452A (no)
PL (1) PL310207A1 (no)
TR (1) TR199500885A2 (no)
YU (1) YU57495A (no)
ZA (1) ZA957281B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010068707A (ko) * 2000-01-07 2001-07-23 최용준 시계줄
JP2001240534A (ja) * 2000-02-29 2001-09-04 Bio Kagaku Kk 液状組成物
KR102178793B1 (ko) * 2019-04-17 2020-11-13 황용석 순금 장식연결구

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760075A (en) * 1980-10-02 1988-07-26 Eli Lilly And Company N-thiazolylmethylthioalkyl-N-alkyl-amidines and related compounds
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4375547A (en) * 1980-10-02 1983-03-01 Eli Lilly And Company N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
FI840474A (fi) * 1983-02-07 1984-08-08 Lilly Co Eli Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna.
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
US4857344A (en) 1986-12-31 1989-08-15 Del Monte Corporation Method for treating pineapple to inhibit browning
EP0285681B1 (de) * 1987-04-06 1993-03-10 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von Nitroethenderivaten
EP0396830B1 (en) * 1989-05-10 1993-10-27 Council of Scientific and Industrial Research An improved process for the preparation of 1-substituted amino-1-substituted thio-2-nitro alkenes
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
US5334725A (en) * 1991-05-21 1994-08-02 Eli Lilly And Company 2-aminomethyl-4-exomethylenethiazoline epoxides
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same

Also Published As

Publication number Publication date
HU9502542D0 (en) 1995-10-30
NZ272833A (en) 1997-04-24
PE33696A1 (es) 1996-08-29
HUT72672A (en) 1996-05-28
US5470865A (en) 1995-11-28
YU57495A (sh) 1999-07-28
CA2157240A1 (en) 1996-03-01
FI954050A (fi) 1996-03-02
IL115012A0 (en) 1996-01-31
AU3033495A (en) 1996-03-14
ES2145221T3 (es) 2000-07-01
PL310207A1 (en) 1996-03-04
DE69516475T2 (de) 2000-09-28
EP0704214B1 (en) 2000-04-26
PH31452A (en) 1998-11-03
EP0704214A1 (en) 1996-04-03
CZ189395A3 (en) 1996-03-13
CO4410183A1 (es) 1997-01-09
KR960006921A (ko) 1996-03-22
ATE192039T1 (de) 2000-05-15
NO952825D0 (no) 1995-07-17
DE69516475D1 (de) 2000-05-31
AU700488B2 (en) 1999-01-07
TR199500885A2 (tr) 1996-06-21
JPH0892087A (ja) 1996-04-09
FI954050A0 (fi) 1995-08-29
CN1127635A (zh) 1996-07-31
ZA957281B (en) 1997-02-28
BR9503832A (pt) 1996-09-10

Similar Documents

Publication Publication Date Title
NO178378C (no) Fremgangsmåte for fremstilling av peroksidiske perfluorpolyetere
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
NO176823C (no) Fremgangsmåte for fremstilling av fermentert soyasaus
DK0613894T3 (da) N-Heteroaryl-N'-phenylurinstofderivater, fremstilling og anvendelse deraf
NO953254D0 (no) Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter
NO944075L (no) Fremgangsmåte for fremstilling av (S)-3-amino-1-substituert pyrrolidiner
NO924690L (no) Fremgangsmaate for fremstilling av mono-n-substituerte tetraazakrocykluser
NO961252L (no) Fremgangsmåte for fremstilling av N-metyl-3-(1-metyl-4-piperidinyl)-14-indol-5-etansulfonamid
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO991733D0 (no) FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering
NO952825L (no) Farmasöytisk preparat
NO881884D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO955185D0 (no) Fremgangsmåte for fremstilling av et isobutan-/isoheksanholdig produkt
NO178782C (no) Fremgangsmåte for fremstilling av et farmasöytisk akseptabelt gelpreparat
FI906162A (fi) Foerfarande foer framstaellning av 3-(n-metyl-n-alkyl)-amino-2-metoximetylenpropan-1-olderivat.
NO981798D0 (no) FremgangsmÕte for fremstilling av faste legemiddelformer
NO974846D0 (no) Fremgangsmåte for fremstilling av Form 1 Ranitidin-Hydroklorid
NO972605D0 (no) Ny fremgangsmåte for fremstilling av ranitidin
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
NO940387D0 (no) Fremgangsmaate for fremstilling av et azihydrokarbon
FR2693723B1 (fr) Dérivés de la N-(phényléthyl-beta-ol) amine ainsi que leur procédé de préparation.
NO901732L (no) Fremgangsmaate for fremstilling av 4-alkoksyalkyl-4-aminofenylpiperidiner og derivater derav.
MY104318A (en) Novel thiopen compounds and their preparation
SE9300226D0 (sv) Foerfarande foer delignifiering av lignocellulosahaltig massa
FI960790A0 (fi) Menetelmä fluoreenibisfenolin valmistamiseksi